Multiple sclerosis (MS) is a chronic autoimmune disorder affecting movement, sensation, and bodily functions. It is caused by destruction of the myelin insulation covering nerve fibers (neurons) in the central nervous system (brain and spinal cord).
Does smoking compound other MS risk factors? – Smoking may increase the risk of multiple sclerosis (MS) in people who also have specific established risk factors for MS. The research is found in the April_7, 2010, online issue of Neurology?, the medical journal of the American Academy of Neurology.
FDA Approves Ampyra to Improve Walking in Adults with Multiple Sclerosis – The U.S. Food and Drug Administration approved Ampyra (dalfampridine) extended release tablets to improve walking in patients with multiple sclerosis (MS).
Study confirms that cannabis is beneficial for multiple sclerosis – Cannabis can reduce spasticity (involuntary muscle tension or contraction) in multiple sclerosis (MS) patients, revealed by researchers in a new study.
There is good news for women with multiple sclerosis (MS) who are pregnant or thinking about becoming pregnant. – Pregnant women with multiple sclerosis are only slightly more likely to have cesarean deliveries and babies with a poor prenatal growth rate than women who do not have multiple sclerosis (MS), revealed by US researchers.
Teenage obesity linked to increased risk of MS – Teenage women who are obese may be more than twice as likely to develop multiple sclerosis (MS) as adults compared to female teens who are not obese, revealed by researchers.
Smoking linked to increased brain lesions and brain shrinkage in MS – People who smoke and have multiple sclerosis (MS) may be at increased risk of brain shrinkage and increased brain lesions related to the disease, revealed by researchers.
Smoking associated with more rapid progression of multiple sclerosis — Smokers at higher risk of developing multiple sclerosis. – Patients with multiple sclerosis who smoke appear to experience a more rapid progression of their disease, revealed by researchers in the Archives of Neurology.
Aussie and Kiwi researchers make double MS genetic discovery – 2 new locations of genes causing multiple sclerosis. – Two new locations of genes responsible for multiple sclerosis are discovered which will help to unravel the causes of MS and other autoimmune disease, revealed by Australian and New Zealand researchers
MS Society supports national Carers Week – New research launched to mark the start of national Carers Week (8-13 June) shows that almost three-quarters (74%) of carers have reached breaking point due to the pressures of their caring role.
Breastfeeding associated with a reduced risk of relapse in women with multiple sclerosis – Women with multiple sclerosis who breastfeed exclusively for at least two months appear less likely to experience a relapse within a year after their baby’s birth, according to a report that will appear in the August print issue of Archives of Neurology, one of the JAMA/Archives journals.
Prescribing sunshine for multiple sclerosis? — Encouraging patients with multiple sclerosis to spend more time in the sun – might be a cheap and easy treatment. – Could a holiday in the sun reduce the risk of developing multiple sclerosis? In a recent review for F1000 Medicine Reports, Bridget Bagert and Dennis Bourdette highlight recent advances in potential treatments.
Acorda Therapeutics Announces FDA Acceptance of Fampridine-SR New Drug Application for Filing. FDA Assigns Priority Review and PDUFA Date of October_22, 2009. – Acorda Therapeutics, Inc. (Nasdaq: ACOR) announced that the U.S. Food and Drug Administration (FDA) has accepted the Fampridine-SR New Drug Application (NDA) for filing, assigning Priority Review and a Prescription Drug User Fee Act (PDUFA) date of October_22, 2009.
